Thrombophilia: a new factor emerges from the mists

An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B.

Journal of thrombosis and haemostasis : JTH·2013

Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy.

Journal of thrombosis and haemostasis : JTH·2010

Optimizing warfarin reversal--an ex vivo study.

Journal of thrombosis and haemostasis : JTH·2009

450 million years of hemostasis.

Journal of thrombosis and haemostasis : JTH·2003

Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins.

Xenotransplantation·2001

Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r)).

British journal of haematology·2001

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Using the UTAUT model to understand HIV-negative MSM's intention to use a proposed HIV prevention mHealth management system: A cross-sectional study.

Digital health·2026

Discovery of thienopyrimidine analog G-18 as a novel anti-trichomonal agent.

International journal for parasitology. Drugs and drug resistance·2026

Tissue-specific molecular responses to salinomycin and their modulation by ionophore-antibiotic interactions in turkeys.

Poultry science·2026

The efficacy and safety of the XEN63 glaucoma gel stent without Mitomycin C over the first 10 years.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026

Profound vagal hyperreactivity unmasked after pacemaker implantation: a rare indication for cardioneuroablation-a case report.

European heart journal. Case reports·2026

Debunking Misconceptions and Highlighting Common Denominators and Differences: VHP Sterilization vs. Bio-Decontamination: Poster Presented at PDA Week 2026.

PDA journal of pharmaceutical science and technology·2026

Related Experiment Videos

Thrombophilia: a new factor emerges from the mists

Related Concept Videos

An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B.

Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy.

Optimizing warfarin reversal--an ex vivo study.

450 million years of hemostasis.

Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins.

Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r)).

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Using the UTAUT model to understand HIV-negative MSM's intention to use a proposed HIV prevention mHealth management system: A cross-sectional study.

Discovery of thienopyrimidine analog G-18 as a novel anti-trichomonal agent.

Tissue-specific molecular responses to salinomycin and their modulation by ionophore-antibiotic interactions in turkeys.

The efficacy and safety of the XEN63 glaucoma gel stent without Mitomycin C over the first 10 years.

Profound vagal hyperreactivity unmasked after pacemaker implantation: a rare indication for cardioneuroablation-a case report.

Debunking Misconceptions and Highlighting Common Denominators and Differences: VHP Sterilization vs. Bio-Decontamination: Poster Presented at PDA Week 2026.

Related Experiment Videos

Thrombophilia: a new factor emerges from the mists

Related Concept Videos

Related Articles